// App-Quantinova.ai

656 : Histological and 3D morphological evaluation of mammary cancers and primary cells from genetically engineered mice with only one copy of Brca1 disrupted in combination with Trp53 haploinsufficiency

Researchers

Presenter

  • Sahar J. Alothman

Principal Investigators

  • Weisheng Wang

  • Bhaskar V. Kallakury

  • Priscilla Furth

Medical Centers

  • Georgetown University, Washington, DC

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Ligand 28

  • Proliferation marker protein Ki-67

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved